Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses
**Background:** Studies have shown that improvements in glycemic control are associated with avoidance or delayed onset of diabetes complications, improvements in health-related quality of life, and reductions in diabetes-related health care costs. Clinical practice guidelines recommend maintaining...
Saved in:
Main Authors: | John E. Schneider, Anjani Parikh, Ivana Stojanovic |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2018-02-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9783 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sick Day Management for Adults with Diabetes Who Take Insulin
by: Nancy J. Gal, et al.
Published: (2012-03-01) -
Sick Day Management for Adults with Diabetes Who Take Insulin
by: Nancy Gal, et al.
Published: (2017-08-01) -
Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey
by: Ilhan Satman, et al.
Published: (2013-08-01) -
Autophagy-lysosome pathway in insulin & glucagon homeostasis
by: Yi Wu, et al.
Published: (2025-02-01) -
Does insulin resistance contribute to the ‘unbrowning’ of brown adipose tissue?
by: Orien L. Tulp
Published: (2023-03-01)